key: cord-0791543-2ozvp0na
authors: Abouelela, Mohamed E.; Assaf, Hamdy K.; Abdelhamid, Reda A.; Elkhyat, Ehab S.; Sayed, Ahmed M.; Oszako, Tomasz; Belbahri, Lassaad; El Zowalaty, Ahmed E.; Abdelkader, Mohamed Salaheldin A.
title: Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Aloe: An In Silico Study for Drug Development
date: 2021-03-21
journal: Molecules
DOI: 10.3390/molecules26061767
sha: fc671fca22408dc5edb5092aa71235e44c0064b4
doc_id: 791543
cord_uid: 2ozvp0na

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) disease is a global rapidly spreading virus showing very high rates of complications and mortality. Till now, there is no effective specific treatment for the disease. Aloe is a rich source of isolated phytoconstituents that have an enormous range of biological activities. Since there are no available experimental techniques to examine these compounds for antiviral activity against SARS-CoV-2, we employed an in silico approach involving molecular docking, dynamics simulation, and binding free energy calculation using SARS-CoV-2 essential proteins as main protease and spike protein to identify lead compounds from Aloe that may help in novel drug discovery. Results retrieved from docking and molecular dynamics simulation suggested a number of promising inhibitors from Aloe. Root mean square deviation (RMSD) and root mean square fluctuation (RMSF) calculations indicated that compounds 132, 134, and 159 were the best scoring compounds against main protease, while compounds 115, 120, and 131 were the best scoring ones against spike glycoprotein. Compounds 120 and 131 were able to achieve significant stability and binding free energies during molecular dynamics simulation. In addition, the highest scoring compounds were investigated for their pharmacokinetic properties and drug-likeness. The Aloe compounds are promising active phytoconstituents for drug development for SARS-CoV-2.

SARS-CoV-2, a novel coronavirus disease caused by Severe Acute Respiratory Syndrome Coronavirus 2, an RNA β-coronavirus, poses an increasing threat to human health. To date, SARS-CoV-2 has infected 105 million people worldwide (https://www.worldometers.info/, accessed on 20 February 2021). The disease is manifested by fever, cough, dyspnea and pneumonia with unknown etiology that worsens over time and can lead to death [1, 2] . In addition, SARS-CoV-2 patients develop low levels of neutralizing antibodies leading to prolonged disease [3] . Entry of SARS-CoV-2 into host cells is a critical factor in its pathogenesis. The surface-anchored spike proteins of SARS-CoV-2 are key determinants of viral entry. They 36 .3%, chromones 27.4%, coumarin 0.8%, flavonoids 4.2%, simple phenolic compounds 8%, phenyl pyran and phenyl pyrone derivatives 7%, benzofurans 2%, naphthalene derivatives 5.9%, alkaloids 1.2%, fatty acid derivatives 1.2% and miscellaneous compounds 5.5%.

High-throughput virtual screening of compounds from Aloe, was followed by molecular docking and MD simulation. Since ligand binding to a protein of interest is the first step in drug discovery, molecular docking is widely used to predict and identify ligands that fit into the binding pocket of a protein of interest [28] . Our screening was performed against two major drug discovery and therapeutic targets of SARS-CoV-2, spike glycoprotein and M pro proteins [7, 12] . SARS-CoV-2 main protease M pro is critical for the life cycle of the virus. Approximately, two thirds of the SARS-CoV-2 genome is translated into polyproteins pp1a and pp1ab, that are cleaved with M pro into nonstructural proteins that are involved in the production of viral membrane, spike and nucleocapsid proteins [29] . M pro is a dimer that has cysteine and histidine in the active site which form a catalytic dyad, conserved among coronaviruses making it an ideal therapeutic target [12] . In molecular docking studies, the ligand-receptor interaction with protein active site residues is established by formation of some interactions including hydrogen bonds, Van der Waal force 36 .3%, chromones 27.4%, coumarin 0.8%, flavonoids 4.2%, simple phenolic compounds 8%, phenyl pyran and phenyl pyrone derivatives 7%, benzofurans 2%, naphthalene derivatives 5.9%, alkaloids 1.2%, fatty acid derivatives 1.2% and miscellaneous compounds 5.5%.

High-throughput virtual screening of compounds from Aloe, was followed by molecular docking and MD simulation. Since ligand binding to a protein of interest is the first step in drug discovery, molecular docking is widely used to predict and identify ligands that fit into the binding pocket of a protein of interest [28] . Our screening was performed against two major drug discovery and therapeutic targets of SARS-CoV-2, spike glycoprotein and M pro proteins [7, 12] . SARS-CoV-2 main protease M pro is critical for the life cycle of the virus. Approximately, two thirds of the SARS-CoV-2 genome is translated into polyproteins pp1a and pp1ab, that are cleaved with M pro into nonstructural proteins that are involved in the production of viral membrane, spike and nucleocapsid proteins [29] . M pro is a dimer that has cysteine and histidine in the active site which form a catalytic dyad, conserved among coronaviruses making it an ideal therapeutic target [12] . In molecular docking studies, the ligand-receptor interaction with protein active site residues is established by formation of some interactions including hydrogen bonds, Van der Waal force interaction, π-sigma bond, π-π interaction, electrostatic interaction, and many other hydrophobic interactions. Hydrogen bonds are essential for interaction, lowering the binding energy and stabilizing the ligand-receptor docked complex. Pharmacologically, it is well-known that blockade of a receptor active site by a ligand terminates its functional activity [30] . Our molecular docking approach was validated by docking of hydroxychloroquine, a potent inhibitor of SARS-CoV-2 M pro . Hydroxychloroquine acts as a lysomotropic agent that inhibits viral entry and viral endocytosis. Viral entry and replication are highly dependent on the acidic pH of lysosomes and endosomes, and some host proteases which are also active in acidic pH (pH 5-5.5) [31] . Chloroquine and its analogues are diprotic weak bases that in their unprotonated forms, readily diffuse through cellular and organelle membranes such as lysosomes, endosomes and Golgi vesicles increasing pH from 6.3 to 6.7 [32] [33] [34] . In addition to disruption of endocytic pathway pH, chloroquine and hydroxychloroquine have been recently found to be potent inhibitors of SARS-CoV-2 M pro but not viruses that belong to Rhabdoviridae [35] . In our study, the compounds previously isolated from Aloe plants were virtually screened against SARS-CoV-2 main protease M pro (PDB ID: 6LU7) ( Figure 2 ) and spike glycoprotein (PDB ID: 6M0J) ( Figure 2 ) to find potential inhibitors for SARS-CoV-2. Using our docking approach, hydroxychloroquine interacted with SARS-CoV-2 protein M pro and docked hydroxychloroquine bound to the active site with and RMSD of 1.2 Å. Molecular docking data were filtered to remove compounds with scores > −6.5 for both SARS-CoV-2 main protease M pro ( Figure 3 and Table A1 ) and spike glycoprotein ( Figure 4 and Table A1 ). Molecular docking was performed by examining the interactions of these compounds with the active site residues of these proteins and analysis of results.

interaction, π-sigma bond, π-π interaction, electrostatic interaction, and many other hydrophobic interactions. Hydrogen bonds are essential for interaction, lowering the binding energy and stabilizing the ligand-receptor docked complex. Pharmacologically, it is well-known that blockade of a receptor active site by a ligand terminates its functional activity [30] . Our molecular docking approach was validated by docking of hydroxychloroquine, a potent inhibitor of SARS-CoV-2 M pro . Hydroxychloroquine acts as a lysomotropic agent that inhibits viral entry and viral endocytosis. Viral entry and replication are highly dependent on the acidic pH of lysosomes and endosomes, and some host proteases which are also active in acidic pH (pH 5-5.5) [31] . Chloroquine and its analogues are diprotic weak bases that in their unprotonated forms, readily diffuse through cellular and organelle membranes such as lysosomes, endosomes and Golgi vesicles increasing pH from 6.3 to 6.7 [32] [33] [34] . In addition to disruption of endocytic pathway pH, chloroquine and hydroxychloroquine have been recently found to be potent inhibitors of SARS-CoV-2 M pro but not viruses that belong to Rhabdoviridae [35] . In our study, the compounds previously isolated from Aloe plants were virtually screened against SARS-CoV-2 main protease M pro (PDB ID: 6LU7) ( Figure 2 ) and spike glycoprotein (PDB ID: 6M0J) ( Figure 2 ) to find potential inhibitors for SARS-CoV-2. Using our docking approach, hydroxychloroquine interacted with SARS-CoV-2 protein M pro and docked hydroxychloroquine bound to the active site with and RMSD of 1.2 Å . Molecular docking data were filtered to remove compounds with scores > −6.5 for both SARS-CoV-2 main protease M pro (Figure 3 and Table A1) and spike glycoprotein ( Figure 4 and Table A1 ). Molecular docking was performed by examining the interactions of these compounds with the active site residues of these proteins and analysis of results. Compounds scoring lower than −5.00 kcal/mol are expected to be active. These compounds were then filtered by RMSD value [30] , to evaluate experimental stability of the docked ligand conformers. RMSD values around 1.5 Å , are considered successful and stable while those beyond 2 Å indicate instability of ligand conformation and docking parameters [36] . For SARS-CoV-2 protein M pro , the binding energy observed for these compounds ranged from−7.950 to −0.339 kcal/mol while for spike glycoprotein, binding energy ranged from −8.088 to −5.437 kcal/mol. The top three scoring compounds for SARS-CoV-2 protein M pro were compound 132 (2′-oxo-2′-O-(3,4-dihydroxy-E-cinnamoyl)-(2′R) aloesinol-7-methyl ether), compound 134 (2′-oxo-2′-O-(4-hydroxy-3-methoxy-(E)-cinnamoyl)-(2′R)-aloesinol-7-methyl ether) and compound 159 (rutin), (Table 1 docking scores and Figure 5 , top panel). These three compounds showed the strongest interaction with the active site of SARS-CoV-2 protein M pro . Molecular 2D and 3D interactions complexes of compounds 132, 134 and 159 with SARS-SARS-CoV-2 protein M pro are shown in Figure 6 . Compounds scoring lower than −5.00 kcal/mol are expected to be active. These compounds were then filtered by RMSD value [30] , to evaluate experimental stability of the docked ligand conformers. RMSD values around 1.5 Å, are considered successful and stable while those beyond 2 Å indicate instability of ligand conformation and docking parameters [36] . For SARS-CoV-2 protein M pro , the binding energy observed for these compounds ranged from−7.950 to −0.339 kcal/mol while for spike glycoprotein, binding energy ranged from −8.088 to −5.437 kcal/mol. The top three scoring compounds for SARS-CoV-2 protein M pro were compound 132 (2 -oxo-2 -O-(3,4-dihydroxy-E-cinnamoyl)-(2 R) aloesinol-7-methyl ether), compound 134 (2 -oxo-2 -O-(4-hydroxy-3-methoxy-(E)cinnamoyl)-(2 R)-aloesinol-7-methyl ether) and compound 159 (rutin), (Table 1 docking scores and Figure 5 , top panel). These three compounds showed the strongest interaction with the active site of SARS-CoV-2 protein M pro . Molecular 2D and 3D interactions complexes of compounds 132, 134 and 159 with SARS-SARS-CoV-2 protein M pro are shown in Figure 6 .

On the other hand, the top three scoring compounds for SARS-CoV-2 spike glycoprotein were compounds compound 115 (2"-O-(4-methoxycinnamoyl)-(S)-aloesinol), compound 120 (rabaichromone), and compound 131 (aloeribide), (Table 1 docking score, and Figure 5 On the other hand, the top three scoring compounds for SARS-CoV-2 spike glycoprotein were compounds compound 115 (2′′-O-(4-methoxycinnamoyl)-(S)-aloesinol), compound 120 (rabaichromone), and compound 131 (aloeribide), (Table 1 docking score, and Figure 5 , lower panel). These three compounds showed the strongest interaction with SARS-CoV-2 RBD. Molecular 2D and 3D interactions complexes of compounds 115, 120 and 131 with SARS-SARS-CoV-2 protein spike glycoprotein receptor binding domain are shown in Figure 7 . In depth analysis showed that chromone derivatives 132 and 134 had high binding affinity as lead compounds for developing SARS-CoV-2 M pro inhibitors. These compounds had a score of −7.683 kcal/mol (RSMD = 1.37) and −7.951 kcal/mol (RSMD = 1.72), respectively (Table 1 ).

x FOR PEER REVIEW 6 of 29 Table 1 ). In addition, the flavonoid compound 159 forms a hydrogen bond with the M pro protein THR190A amino acid residue with −7.728 kcal/mol as scoring value ( Figure 6A3 ,B3 and Table 1 ). Regarding the interaction of the compounds with SARS-CoV-2 spike glycoprotein, this was mainly supported by hydrogen bonds, π-H, ionic and hydrophobic interactions. The highest scoring compounds were the chromone derivatives 115 (2"-O-(4-methoxycinnamoyl)-(S)-aloesinol), 120 (rabaichromone) and 131 (aloeribide) with binding energies −8.057, −7.871 and −8.088 kcal/mol, respec- Table 1 ). Moreover, compound 131 interacted with GLN102A, ASN210A and ASP206A ( Figure 7A2 ,B2 and Table 1 ) by π i-H bond while compound 120 formed hydrogen bonds with ALA396A, ASP206A and GLU208A amino acid residues ( Figure 7A3 ,B3 and Table 1 ). 

Conventional docking approaches do not account for the inherent protein binding site flexibility and the many protein conformational rearrangements [37] . Computational tools for drug discovery such as molecular dynamics take into account structural flexibility and entropic effects which produce accurate predictions of small molecule-protein binding thermodynamics and kinetics [38] . Hence dynamical docking considers flexibility of drug-protein binding and conformational changes, solvation of drug-protein complex and temperature [38, 39] . Unbiased millisecond-long can predict spontaneous drug-protein entire binding [40] . In addition, recent developments in dynamical docking such as 

Conventional docking approaches do not account for the inherent protein binding site flexibility and the many protein conformational rearrangements [37] . Computational tools for drug discovery such as molecular dynamics take into account structural flexibility and entropic effects which produce accurate predictions of small molecule-protein binding thermodynamics and kinetics [38] . Hence dynamical docking considers flexibility of drug-protein binding and conformational changes, solvation of drug-protein complex and temperature [38, 39] . Unbiased millisecond-long can predict spontaneous drug-protein entire binding [40] . In addition, recent developments in dynamical docking such as enhanced sampling for dynamical docking, path-based and alchemical transformations have greatly impacted drug discovery [38] . To validate molecular docking results, we subjected the top scoring compounds to unbiased molecular dynamics simulation experiments. The three top scoring M pro inhibitor hits 132, 134, and 159 were able to achieve stable binding inside the active site with low deviations across the course of simulations (Average RMSD = 3.22, 3.32, and 3.86 Å, respectively) and convergent binding free energies (∆G = −6.9, −6.8, and −6.5 kcal/mol, respectively), ( Figure 8A ). 

Drug-like properties and pharmacokinetic properties are intrinsic characteristi drugs that may need to be optimized independently from pharmacodynamics prope during drug development. It is a balance among molecular properties affecting pha codynamics and pharmacokinetics of small molecules. These molecular properties as membrane permeability and bioavailability are always connected to some basic m ular descriptors such as lipophilicity log P, (Tendency of a compound to partition int aqueous matrix versus lipid matrix), molecular weight (MW), topological polar sur area (TPSA), or hydrogen bond acceptors and donors count in a molecule. Lipophil impacts drug's absorption, distribution, metabolism, elimination (ADME) and pla protein binding properties. In addition, the number of hydrogen bond donors and hy gen bond acceptors influence drug's pKa (−log Ka). The solubility of small molecules pacts their bioavailability and the need for frequent dosing, hence we investigated With respect to SARS-CoV-2 spike glycoprotein, both compounds 120 and 131 were stable inside the binding site during MD simulation, with scoring average RMSDs of 2.81 Å and 3.96 Å, respectively, and ∆G of −7.4 and −6.8 kcal/mol, respectively ( Figure 8B ). On the other hand, compound 115 was significantly less stable (average RMSD = 6.2 Å) inside the SARS-CoV-2 spike glycoprotein binding site, and this instability was further translated into a low binding free energy (∆G = −4.5 kcal/mol) compared to compounds 120 and 131 ( Figure 8B ). RMSF is an expression of the average residual mobility throughout simulation in a structure and a higher RMSF value indicates more flexibility during MD simulation. We calculated the RMSF value for the top scoring compounds from Aloe genus with SARS-CoV-2 M pro and SARS-CoV-2 spike glycoprotein and plotted RMSF value versus residue number ( Figure 8C,D) . The results indicate that compounds 159 and 120 had high RMSF values compared to other compounds. The RMSD and RMSF values indicate that the top scoring compounds from Aloe genus were stable and had greater random motion during the simulation. The inhibitors identified in in our docking analysis that showed interaction with SARS CoV-2 spike protein and M Pro are in agreement with previously reported results [41] . Arokiyaraj et al. found that several polyphenolic compounds from Geranii Herba, including geraniin, kaempferitrin, quercitin, gallic acid, and kaempferol interacted with amino acid residues in the SARS-CoV-2 RBD active site inhibiting the interaction of SARS-CoV-2 RBD with ACE2. Arokiyaraj et al. also reported that these polyphenolic compounds interacted strongly with amino acids in the active site of SARS-CoV-2 M pro and its proximity leading to blockade of the nucleophilic attack toward His 41 and blockade of proteolytic activity. In agreement with this, we found that quercetin interacted with SARS CoV-2 RBD and M pro with binding energies of −5 Kcal/mol and −5.5 Kcal/mol respectively, similar to the results reported by Arokiyaraj et al. for quercetin interaction with RBD and M pro −5.71 Kcal/mol and −6.49 kcal/mol, respectively. In addition, we found that gallic acid interacted with SARS CoV-2 RBD and M pro with binding energies of −4.19 Kcal/mol and −3.56 Kcal/mol, respectively, similar to the binding energies reported by Arokiyaraj et al. for the gallic acid interaction with SARS CoV-2 RBD and M pro , −4.21 kcal/mol and −4.46 kcal/mol, respectively. These finding indicate that phenolic compounds from Aloe are potential inhibitors for SARS CoV-2 RBD and M pro [41] .

Drug-like properties and pharmacokinetic properties are intrinsic characteristics of drugs that may need to be optimized independently from pharmacodynamics properties during drug development. It is a balance among molecular properties affecting pharmacodynamics and pharmacokinetics of small molecules. These molecular properties such as membrane permeability and bioavailability are always connected to some basic molecular descriptors such as lipophilicity log P, (Tendency of a compound to partition into an aqueous matrix versus lipid matrix), molecular weight (MW), topological polar surface area (TPSA), or hydrogen bond acceptors and donors count in a molecule. Lipophilicity impacts drug's absorption, distribution, metabolism, elimination (ADME) and plasma protein binding properties. In addition, the number of hydrogen bond donors and hydrogen bond acceptors influence drug's pKa (−log Ka). The solubility of small molecules impacts their bioavailability and the need for frequent dosing, hence we investigated the ADME properties, inhibition of cytochrome P450 (CYP), modulation of P-glycoprotein (Pgp), solubility, plasma protein binding and permeability of the top scoring compounds in our analysis. The best scoring compounds for both SARS-CoV-2 M pro and spike glycoprotein were tested for obeying Lipinski's rule of five parameters, which states that drugs having log P ranging from 0 to 5, have high possibility of oral absorption [42] . Data (Table 2) showed that the compounds have log P values that ranged from −1.06 to 2.8 that does not exceed 5.0 indicating reasonable probability of their good absorption. The number of hydrogen bond donors was variable and ranged from 4 to10 that is more than 5 and also hydrogen bond acceptors were 11-16 that is more than 10. All compounds have number of atoms that ranged from 40 to 43 which is within 20-70. In addition, the topological polar surface area (TPSA) of the compounds as parameter for the prediction of drug transport properties showed TPSA value greater than 140 Å 2 tend to be poor at permeating cell membranes. Despite violation of some rules, approved anticancer and anti-infective drugs from natural products or their semisynthetic derivatives such as taxol and amphotericin B have also some violations but are biologically effective as drugs. Therefore, these results don't interfere with the development of these compounds as potential SARS-CoV-2 therapeutic agents [43] . [44] . All compounds showed medium Caco-2 predicted permeability and medium MDCK predicted cell permeability [45] . Moreover, all compounds showed moderate predicted plasma protein binding (PPB) (Table S1) except for compound 159, which showed weak predicted PPB, which indicates predicted decreased excretion and increased predicted half-life. It is important to consider drug's interaction with plasma proteins, transporters and CYP450s for the successful selection of drug candidate. CYP2C19 and CYP2C9 inhibition leads to increased drug plasma concentration, leading to potential side effects [46, 47] . All top scoring compounds were predicted to inhibit CYP2C19 and CYP2C9. CYP2D6 metabolizes many drugs and toxins [48] . None of the top scoring compounds showed predicted inhibitory activity to CYP2D6. CYP3A4 is also involved in metabolism of xenobiotics and is highly expressed in the liver and intestine [49] . The six top scoring compounds were predicted to inhibit CYP3A4. Drug resistance is a major concern in drug development. Multidrug resistance is regulated by a network of ATP-binding cassette (ABC) proteins that detoxify xenobiotics and act as drug transporters and efflux pumps. P glycoprotein (Pgp; ABCB1) is the most popular and well-studied efflux pump [50, 51] . Pgp has intrinsic ATPase activity to drive active transport and generate a concentration gradient leading to transport of drugs to the extracellular space and inhibition of drug activity [51] . Pgp is highly expressed in blood-brain barrier cell, liver, intestine and kidney. Thus, it is important to predict drug's binding to Pgp. Only compound 115 was predicted to inhibit Pgp and hence it may affect the activity or excretion of other Pgp substrates. Compound 159 had the highest water solubility (217.207 mg/L) while the other five compounds had low water solubility, hence this should be considered during drug development. In addition, skin permeability is an important factor to consider during drug development for the potential of dermal drug delivery and risk assessment of drugs that may contact skin [52] . Skin permeability also increases drug's plasma concentration and activity. It has been reported that logP between −3 to +6 predict drug's skin permeability [53] . SKlogD, SKlogP and SKlogS are related to drugs' skin permeability and lipophilicity. All the six top scoring compounds had skin permeability values ranging from −4.6 to −3.6, indicating that they may not be absorbed through skin and thus should not pose a dermal exposure risk. Finally, all compounds did not have predicted ability to pass the blood brain barrier (BBB) and are not expected to be neurotoxic.

Intensive review of the literatures in ScienceDirect, PubMed, SciFinder and has been conducted to identify compounds from Aloe genus.

In this study, two SARS-CoV-2 proteins which facilitate viral-host interaction and replication were selected from the RCSB protein databank (https://www.rscb.org/pdb, accessed on 20 February 2021). The proteins are SARS-CoV-2 main protease (PDB ID: 6LU7, resolution = 2.16 Å) [54] and spike glycoprotein (PDB ID: 6M0J, resolution = 2.45 Å) [42] . The 3D protein structures were prepared using Molecular Operating Environment software (MOE 2014.0901) Ligx option. The site finder function used to calculate and predict possible active potential site of selected proteins for ligand binding in the receptor. PyMol 2.3 software was used for visualization.

Reviewing the available literatures identified 237 phytochemical compounds that were isolated from genus Aloe (Table A1 and Figures S1-S18). All these molecular structures were imported to MOE and subjected to 3D protonation and energy minimization using MMFF94s force field and ligand database was constructed. Ligand coordinate files were extracted from PDB files and used as reference structures for root mean square deviation (RMSD) calculations.

Flexible ligand-rigid receptor docking was performed with MOE-DOCK for molecular docking. The parameters of scoring were Triangle Matcher, scoring was set at London dG with 30 output poses and rescoring at GBVI/WSA dG retaining 10 refined poses. The docking score, root mean square deviation (RSMD), 2D and 3D interactions were recorded [55] . The results of docked ligands are chosen based on the most negative docking score. The docking score represents the best-bound ligand conformations and relative binding affinities. The best-docked conformations for comparison of the binding of the drugs and targets of SARS-CoV2 were selected based on number of hydrogen bonds, binding energy (kcal/mol), upper and lower bound RMSD, number of interacting residues, and forces which stabilized the receptor-ligand complex. RMSD and RMSF of the ligand interaction with the target protein were calculated using the following formulas:

where N is the number of atoms, t ref is the reference time, r is the position of the selected atoms in frame x after superimposing on the reference frame, frame x recorded at time t x , T is the trajectory time over which the RMSF was calculated, r is the position of an atom. Poses of docked compounds are automatically calculated by docking function in Molecular Operating Environment software.

MD simulation experiments were performed as previously described [43] . Briefly, the Molecular Dynamics (NAMD) 2.6 software [45] , employing the CHARMM27 force field [56] was used for simulations. Hydrogen atoms were added to initial coordinates of proteins using the psfgen plugin included in the Visual Molecular Dynamics (VMD) 1.9 software [57] . Subsequently, the protein systems were solvated using TIP3P water particles and 0.15 M NaCl. The equilibration procedure comprised 1500 minimization steps followed by 30 ps of MD simulation at 10 K with fixed protein atoms. Then, the entire systems were minimized over 1500 steps at 0 K, followed by gradual heating from 10 to 310 K using temperature reassignment during the initial 60 ps of the 100 ps equilibration MD simulation. The final step involved NTP simulation (30 ps) using the Nose-Hoover Langevin piston pressure control at 310 K and 1.013 bars for density (volume) fitting [58] . Thereafter, the MD simulation experiments were continued for 25 ns for the entire systems (20 ns for the enzyme-ligand complexes). The trajectory was stored every 0.1 ns and further analyzed with the VMD 1.9 software. The MD simulation output over 25 ns provided several structural conformers that were sampled every 0.1 ns (250 poses) to evaluate conformational changes of the entire protein structure to analyze the RMSD. All parameters and topologies of the compounds selected for MD simulation were prepared using the online software Ligand Reader & Modeler [59] and the VMD Force Field Toolkit (ffTK) [57] . Binding free energy calculations (∆G) were performed using the free energy perturbation (FEP) method through the web-based software Absolute Ligand Binder [60] together with MD simulation software NAMD 2.6 [45] . Hydrogen bonds and hydrophobic interactions between protein and ligand were also analyzed using Protein-Ligand Interaction Profiler [61] .

The drug likeliness of best pose scoring compounds is specified by the Lipinski's rule and molecular properties prediction was calculated by the free access website https: //www.molinspiration.com/cgi-bin/properties, accessed on 20 February 2021. ADME Prediction were determined by PreADMET estimation server website [62] .

In recent years, advances in computational resources and software tools led to emergence of molecular dynamics (docking and scoring tool), as the first phase in drug screening and discovery. In addition, absence of new cell culture models for working safely with highly pathogenic viruses makes virtual screening, docking and dynamics of great importance. Aloe genus is a rich source of phytochemicals with a wide range of therapeutic activity. Several natural products from Aloe have shown strong antiviral activity, inhibiting replication and entry and of HSV-1 and 2, human cytomegalovirus (HCMV), influenza A and polio. Aloin significantly reduces replication of oseltamivir-resistant (H1N1) influenza virus. In our study, we applied computational screening of 237 natural product compounds from Aloe genus and identification of six compounds as stable potential inhibitors of SARS-CoV-2 main protease and spike glycoprotein. Our molecular docking analysis showed that theses six compounds are stable and safe. Compounds 132, 134 and 159 were the top three scoring potential inhibitors of for SARS-CoV-2 main protease. These compounds interacted strongly with amino acids in the active site of SARS-CoV-2 main protease. Rutin (154) is known to have antiviral activity against influenza virus [63] . Compounds 115, 120 and compound 131 were the top scoring potential inhibitors of SARS-CoV-2 spike glycoprotein. The results highlighted chromone derivatives as potential inhibitors for SARS-CoV-2 according to their best scores of binding affinities to the mentioned target proteins among the examined compounds. The results of this in-silico investigation (docking and molecular dynamics simulation) should have a great impact for drug repurposing studies. In the future, in vitro, in vivo and clinical studies shall be conducted to further validate the effectiveness of these compounds as potential treatments for COVID-19 and to identify compounds with best pharmacokinetic profiles. In addition, it will be of great importance to apply newly-developed algorithms and utilize the development of steered molecular dynamics for evaluating the binding of the top scoring compounds to SARS-CoV-2 target proteins [64] .

The following are available online. Figures S1-S18: Compounds isolated from genus Aloe, Table S1 : Predicted pharmacokinetics of top scoring compounds. 

The authors declare that they have no competing financial interests or personal relationships that could influence the work reported in this paper.

Sample Availability: Samples of the compounds are not available from the authors. 

Environmental impact of the COVID-19 pandemic-a lesson for the future

From SARS to COVID-19: A previously unknown SARS-related coronavirus (SARS-CoV-2) of pandemic potential infecting humans-Call for a One Health approach

Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications

Structure, Function, and Evolution of Coronavirus Spike Proteins

Coronaviruses post-SARS: Update on replication and pathogenesis

Receptor Recognition Mechanisms of Coronaviruses: A Decade of Structural Studies

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment

Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence

Quantitative determination of mechanical stability in the novel coronavirus spike protein

Characterization of Structural and Energetic Differences between Conformations of the SARS-CoV-2 Spike Protein

Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs

COVID-19: Drug Targets and Potential Treatments

Drug repurposing and cytokine management in response to COVID-19: A review

COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials

Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19

Antiviral Properties of Flavonoids and Delivery Strategies

Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes

Cripples HIV-1 by Abrogation of Tat Function

Anti-HSV-1 and HSV-2 Flavonoids and a New Kaempferol Triglycoside from the Medicinal Plant Kalanchoe daigremontiana

In vitro anti-HIV-1 activities of kaempferol and kaempferol-7-O-glucoside isolated from Securigera securidaca

Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: A molecular docking study

Assessment of Anti HSV-1 Activity of Aloe Vera Gel Extract: An In Vitro Study

Antiviral activity of Aloe hijazensis against some haemagglutinating viruses infection and its phytoconstituents

Antiviral Activity of Aloe Extracts against Cytomegalovirus

Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza

In silico Molecular Docking Analysis Targeting SARS-CoV-2 Spike Protein and Selected Herbal Constituents

The Many Roles of Computation in Drug Discovery

Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and antipicornavirus drug discovery

Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-COV-2 inhibitors

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

Chloroquine analogues in drug discovery: New directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases

Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19

Elevated Golgi pH impairs terminalN-glycosylation by inducing mislocalization of Golgi glycosyltransferases

Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs

LigRMSD: A web server for automatic structure matching and RMSD calculations among identical and similar compounds in protein-ligand docking

Flexible ligand docking to multiple receptor conformations: A practical alternative

Role of Molecular Dynamics and Related Methods in Drug Discovery

Recent advances in dynamic docking for drug discovery

Proteinligand binding with the coarse-grained Martini model

Geranii Herba as a Potential Inhibitor of SARS-CoV-2 Main 3CL pro , Spike RBD, and Regulation of Unfolded Protein Response

Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease

Microbial natural products as potential inhibitors of SARS-CoV-2 main protease (Mpro)

In silico molecular docking, preclinical evaluation of spiroindimicins A-D, lynamicin A and D isolated from deep marine sea derived Streptomyces sp. SCSIO 03032

Scalable molecular dynamics with NAMD

CYP2C19 Inhibition: The Impact of Substrate Probe Selection on in Vitro Inhibition Profiles

Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs

Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos

The P-Glycoprotein Transport System and Cardiovascular Drugs

Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function

Transdermal drug delivery by passive diffusion and iontophoresis: A review

Mathematical models of skin permeability: An overview

Structure of M pro from SARS-CoV-2 and discovery of its inhibitors

Medicinal Chemistry and the Molecular Operating Environment (MOE): Application of QSAR and Molecular Docking to Drug Discovery

All-atom empirical potential for molecular modeling and dynamics studies of proteins

VMD: Visual molecular dynamics

Constant pressure molecular dynamics algorithms

A web-based graphical user interface for CHARMM

Ligand Binder for Absolute Binding Free Energy Calculations and Its Application

PLIP: Fully automated protein-ligand interaction profiler

An in silico perception for newly isolated flavonoids from peach fruit as privileged avenue for a countermeasure outbreak of COVID-19

Anti-H5N1 virus flavonoids fromCapparis sinaicaVeill

A New Method for Navigating Optimal Direction for Pulling Ligand from Binding Pocket: Application to Ranking Binding Affinity by Steered Molecular Dynamics

Phytochemical investigation of Aloe pulcherrima roots and evaluation for its antibacterial and antiplasmodial activities

Cytotoxic Quinones from the Roots of Aloe dawei

Cytotoxic Compounds from Aloe megalacantha

Chemical constituents of Aloe barbadensis Miller and their inhibitory effects on phosphodiesterase-4D

Chemical Components from Aloe and their Inhibition of Indoleamine 2, 3-dioxygenase

Chemical Constituents from the Flowers of Aloe arborescens

3-c]furan-4,9-dione and its derivatives from Aloe ferox

Secondary metabolites from the resins of Aloe vera and Commiphora mukul mitigate lipid peroxidation

Aloe Plants Accumulate Anthrone-Type Anthranoids in Inflorescence and Leaves, and Tetrahydroanthracenes in Roots

Chemotaxonomic investigations in asphodeleae and aloineae (liliaceae)

Bioactive Compounds Isolated fromAloe ferox.: A Plant Traditionally Used for the Treatment of Sexually Transmitted Infections in the Eastern Cape, South Africa

On the occurrence of aloin in Aloe vera in addition to comparative studies with the fresh juice of Cape aloe (Aloe ferox) and the dried extract prepared from it

Biologically Active Constituents of Leaves and Roots of Aloe arborescens var

Studies on the Constituents of Aloe sapnaria HAW. I. The Structures of Tetrahydroanthracene Derivatives and the Related Anthraquinones

Studies on the constituents of Aloe saponaria Haw. II. The structures of tetrahydroanthracene derivatives, aloesaponol III and -IV

Studies on the constituents of Aloe saponaria Haw. III. The structures of phenol glucosides

Studies on the constituents of Aloe saponaria Haw. IV. The structures of bianthraquinoid pigments

New bioactive compounds fromAloe hijazensis

Screening for novel plant sources of prenyloxyanthraquinones

Anthraquinone, anthrone and phenylpyrone components of Aloe nyeriensis var. kedongensis leaf exudate

Natural urease inhibitors from Aloe vera resin and Lycium shawii and their structural-activity relationship and molecular docking study

Novel Anthrone-Anthraquinone Dimers from Aloe elgonica

Elgonica-Dimers A and B, Two Potent Alcohol Metabolism Inhibitory Constituents of Aloe arborescens

Hypotensive Effect of Chemical Constituents fromAloe barbadensis

Trennung des Aloins in Diastereomere und deren Charakterisierung

Antileishmanial activities of leaf latex and compound isolated from Aloe ghibensis Sebsebe & Friis

LC-MS characterization of bioactive metabolites from two Yemeni Aloe spp. with antioxidant and antidiabetic properties

Structural elucidation of some antimicrobial constituents from the leaf latex of Aloe trigonantha L

Characterization and Evaluation of Antioxidant Activity of Aloe schelpei Reynolds

Free radical scavenging activities of three anthrones from Aloe gilbertii reynolds leaf latex

Phytochemistry and Antileishmanial Activity of the Leaf Latex ofAloe calidophilaReynolds

Diastereomeric C-glucosylanthrones of Aloe vera leaves

Characterisation of a nataloin derivative from Aloe ellenbeckii, a maculate species from east

5-Hydroxyaloin A in the Genus Aloe Thin Layer Chromatographic Screening and High Performance Liquid Chromatographic Determination

Antimalarial evaluation of the leaf latex of Aloe citrina and its major constituent

2 -p-Methoxycoumaroylaloeresin, A C-glucoside from Aloe excelsa

Homonataloin in Aloe species

Anthrones from Aloe microstigma

Three new antioxidantC-glucosylanthrones fromAloe nobilis

Chromones and anthrones from Aloe marlothii and Aloe rupestris

First proof of anthrone aglycones and diastereomeric anthrone-C-glycosyls in flowers and bracts of Aloe species

Isolation of Aloinoside B and Metabolism by Rat Intestinal Bacteria

The chemotaxonomic value of the diglucoside anthrone homonataloside B in the genus Aloe

Microdontin A and B: Two New Aloin Derivatives from Aloe microdonta

Natural phosphodiesterase-4 inhibitors from the leaf skin of Aloe barbadensis Miller

10-Hydroxyaloin B 6'-O-Acetate, an Oxanthrone fromAloe claviflora

Three oxanthrones from Aloe littoralis

Isolation and spectral study of 4-methyl-6, 8-dihydroxy-7H-benz [de] anthracen-7-one

In Vitro Antimicrobial and Antioxidant Activities of Anthrone and Chromone from the Latex of Aloe harlana Reynolds

Anthrones from Aloe barbadensis

Nishioka, I. Formation of tetrahydroanthracene glucosides by callus tissue of Aloe saponaria

Tetrahydroanthracene glucosides in callus tissue from Aloe barbadensis leaves

R)-Prechrysophanol from Aloe graminicola

Aloechrysone, a dihydroanthracenone from Aloe berhana

Engineered Biosynthesis of Plant Polyketides: Chain Length Control in an Octaketide-Producing Plant Type III Polyketide Synthase

Isolation and identification of chromone and pyrone constituents from Aloe and their anti-inflammatory activities

Chromones in Aloe species-Part II-Aloesone

Anthrone and chromone components of Aloe cremnophila and A. jacksonii leaf exudates

Studies on Aloe. 15.1Two New 5-Methylchromones from Cape Aloe

6-Phenylpyrones and 5-methylchromones from Kenya aloe

Constituents of Aloe rubroviolacea

Three chromone components from Aloe vera leaves

Three chromones of Aloe vera leaves

Five chromones from Aloe Vera leaves

Antimicrobial Activity, and Food Preservative Characteristics of Aloe vera Gel. Agronomy

Chemical constituents of the leaves of Chinese aloe (Aloe vera var. chinensis). Zhongcaoyao

Neoaloesin A: A NewC-Glucofuranosyl Chromone fromAloe barbadensis

Aloesin, a C-glucosylchromone from Aloe sp

A novel naphthalene derivative from Aloe barbadensis

Two chromones with antimicrobial activity from the leaf latex of Aloe monticola Reynolds

Mook-Jung, I.; Fang, W.S. BACE1 (beta-secretase) inhibitory chromone glycosides from Aloe vera and Aloe nobilis

AntiinflammatoryC-Glucosyl Chromone fromAloe barbadensis

Aloeresin C, a bitter C, O-diglucoside from Cape Aloe

A C-glucosylated 5-methylchromone from Kenya aloe

Anthracene and chromone derivatives in the exudate of Aloe rabaiensis

Two Chromone Derivatives from Aloe Peglerae

6'-O-Coumaroylaloesin from Aloe castanea-a taxonomic marker for Aloe section Anguialoe

Chromone and aloin derivatives from Aloe broomii, A. Africana and A. speciosa

Aloe revisited the structure of aloeresin A

Iso-aloeresin A, a Minor Constituent of Cape Aloe

Studies on the constituents of Aloe arborescens Mill. var. natalensis Berger. II. The structures of two new aloesin esters

Chemical constituents of Aloe vera

Aloeresin H, a new polyketide constituent of Cape aloe

Aloeresin I, an Anti-Inflammatory 5-Methylchromone from Cape Aloe

The molecular structure of iso-aloesin isolated from the leaves of Aloe vera L. var. chinensis (Haw.) Berge

Cultivation, phytochemical studies, biological activities and medicinal uses of Aloe ferox, grandfather of aloes an important amazing medicinal plant

Phenolic Constituents, Antioxidant and Preliminary Antimycoplasmic Activities of Leaf Skin and Flowers of Aloe vera (L.) Burm. f. (syn. A. barbadensis Mill.) from the Canary Islands (Spain). Molecules

5, 4'-dihydroxy 6, 7, 3', 5'-tetramethoxy flavone 5-O-alpha-L-rhamno pyranosyl 16-O-beta-Dgalactopyranoside from aloe barbadensis (leaves)

4 -Trimethoxy Isoflavone-5-O-alpha-L-Rhamnopy-ranosyl[1→6]-O-beta-D-Glucopyranoside of Aloe vera

Chemical Constituents of Cape Aloe and Their Synergistic Growth-Inhibiting Effect on Ehrlich Ascites Tumor Cells

Studies on the Constituents of Aloe arborescens MILL. var. natalensis BERGER. I. The Structure of Aloearbonaside, a Glucoside of a New Type naturally Occurring Chromene

Aloenin B, a New Diglucosylated 6-Phenyl-2-pyrone from Kenya Aloe

Enzymatic Formation of Unnatural Novel Chalcone, Stilbene, and Benzophenone Scaffolds by Plant Type III Polyketide Synthase

Isolation, structure elucidation, antioxidative and immunomodulatory properties of two novel dihydrocoumarins from Aloe vera

Bioactive chemical constituents from the resin of Aloe vera

Spectral study of a new dihydroisocoumarin

A dihydroisocoumarin glucoside from Aloe hildebrandtii

A New Bisbenzopyran fromAloe barbadensisRoots

Anthraquinones, pre-anthraquinones and isoeleutherol in the roots of Aloe species

A new naphthalene derivative from Aloe vera and its antibacterial activity

Plicataloside, an O,O-diglycosylated naphthalene derivative from Aloe plicatilis

Triglycosylated Naphthalene Derivative from the Exudate of Kenyan Aloe Species

A new triglucosylated naphthalene glycoside from Aloe vera L

A New Benzochromanone Derivative from Cape Aloe †

A chlorinated amide and piperidine alkaloids from Aloe sabaea

Polyketide-Derived Alkaloids and Anthraquinones in Aloe Plants and Cell Cultures

Chemistry of Aloe Species

A dipyrrole derivative from Aloe vera inhibits an anti-diabetic drug target Dipeptidyl Peptidase (DPP)-IV in vitro

Isolation and Chemical Characterization of a New Constituent of Cape Aloe Having the 1,1-Diphenylethane Skeleton

ChemInform Abstract: The isolation, structure determination, and synthesis of pluridone, a novel insecticide from aloe pluridens

Feroxidin, a novel 1-methyltetralin derivative isolated from cape aloe

Absolute configuration of feroxidin: An experimental support to Snatzke's helicity rules for tetralins

Studies on Aloe, Part 10. Feroxins A and B, Two O-Glucosylated 1-Methyltetralins from Cape Aloe

Novel bioactive maloyl glucans from Aloe vera gel: Isolation, structure elucidation and in vitro bioassays